Compile Data Set for Download or QSAR
Report error Found 1117 Enz. Inhib. hit(s) with Target = 'Protein P'
TargetProtein phosphatase 1B(Human)
University of California Irvine

Curated by ChEMBL
LigandPNGBDBM50135699((5R,8S,11R,12S,15S,18S,19S,22R)-8-Isobutyl-18-((1E...)
Affinity DataIC50: 0.300nMAssay Description:Inhibitory concentration against protein phosphatase 1 (PP1) using phosphorylase-a assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein polybromo-1(Human)
University of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM50539801(CHEMBL4648912 | US11840533, Compound 70)
Affinity DataKd: <1nMAssay Description:Binding affinity to human partial length PBRM1 bromodomain 5 (S645 to D766 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetProtein polybromo-1(Human)
University of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM50539801(CHEMBL4648912 | US11840533, Compound 70)
Affinity DataKd: <1nMAssay Description:Binding affinity to human partial length PBRM1 bromodomain 2 (S178 to E291 residues) expressed in bacterial expression system by BROMOscan assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetProtein polybromo-1 [645-766](Human)
Genentech

US Patent
LigandPNGBDBM394585(US10308614, Example 188 | 2-(6-amino-5-(1-(1-)
Affinity DataIC50: 2.5nMAssay Description:Histidine-Flag-PB1-BD5 Bromodomain645-766 (S645-D766; Swiss Prot Q86U86; mhhhhhhasdykddddkgslvprgsSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAI FLRLPSRSELP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetProtein phosphatase 3 catalytic subunit alpha(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50079775(17-Ethyl-1,14-dihydroxy-12-{2-[4-(2-hydroxy-2-naph...)
Affinity DataIC50: 2.80nMAssay Description:Inhibitory activity against Calcineurin (CaN phosphatase)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665511(US20240116910, Compound 195)
Affinity DataIC50: 3nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665345(US20240116910, Compound 29)
Affinity DataIC50: 3nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1B(Human)
University of California Irvine

Curated by ChEMBL
LigandPNGBDBM50135699((5R,8S,11R,12S,15S,18S,19S,22R)-8-Isobutyl-18-((1E...)
Affinity DataIC50: 3nMAssay Description:Inhibitory concentration against protein phosphatase 1 (PP1) using pNPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein phosphatase 1A(Human)
University of California Irvine

Curated by ChEMBL
LigandPNGBDBM50061067(8-[3-amino(imino)methylaminopropyl]-15-isobutyl-5-...)
Affinity DataIC50: 3nMAssay Description:Inhibitory concentration required against protein phosphatase 1 using pNPP assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein polybromo-1 [645-766](Human)
Genentech

US Patent
LigandPNGBDBM394584(US10308614, Example 187 | 2-(6-amino-5-(1-methyl-)
Affinity DataIC50: 3.70nMAssay Description:Histidine-Flag-PB1-BD5 Bromodomain645-766 (S645-D766; Swiss Prot Q86U86; mhhhhhhasdykddddkgslvprgsSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAI FLRLPSRSELP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665472(US20240116910, Compound 156)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665496(US20240116910, Compound 180)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665559(US20240116910, Compound 243)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665495(US20240116910, Compound 179)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665389(US20240116910, Compound 73)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 3 catalytic subunit alpha(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50022815((3S,6S,9S,12R,15S,18S,21S,24S,30S,33S)-30-ethyl-33...)
Affinity DataKd:  4nMAssay Description:Binding affinity to protein phosphatase, calcineurin (CN) was determinedMore data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2012
Entry Details Article

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665423(US20240116910, Compound 107)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 3 catalytic subunit alpha(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50079784(12-{2-[4-(2-Benzo[b]thiophen-2-yl-2-hydroxy-ethoxy...)
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against Calcineurin (CaN phosphatase)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665450(US20240116910, Compound 134)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665449(US20240116910, Compound 133)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665344(US20240116910, Compound 28)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665428(US20240116910, Compound 112)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665385(US20240116910, Compound 69)
Affinity DataIC50: 4nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 3 catalytic subunit alpha(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50079783(12-{2-[4-(2-Benzo[b]thiophen-2-yl-2-hydroxy-ethoxy...)
Affinity DataIC50: 4.20nMAssay Description:Inhibitory activity against Calcineurin (CaN phosphatase)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein phosphatase 3 catalytic subunit alpha(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50079776(17-Ethyl-1,14-dihydroxy-12-(2-{4-[2-hydroxy-2-(3-t...)
Affinity DataIC50: 4.90nMAssay Description:Inhibitory activity against Calcineurin (CaN phosphatase)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665341(US20240116910, Compound 25)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665357(US20240116910, Compound 41)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665560(US20240116910, Compound 244)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665592(US20240116910, Compound 276)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665339(US20240116910, Compound 23)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665494(US20240116910, Compound 178)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665469(US20240116910, Compound 153)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665424(US20240116910, Compound 108)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1 regulatory subunit 1A(Human)
The University of Tokyo

LigandPNGBDBM40785(Calyculinamide A (18))
Affinity DataIC50: 5nMAssay Description:Protein phosphatase inhibitory activity of calyculin derivatives.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/11/2011
Entry Details Article
PubMed
TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665479(US20240116910, Compound 163)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein polybromo-1(Human)
University of Illinois At Chicago

Curated by ChEMBL
LigandPNGBDBM394405(US10308614, Example 6 | (S)-2-(6-amino-5-(2-)
Affinity DataKd:  5nMAssay Description:Binding affinity to PBRM1 bromodomain 2 (unknown origin) assessed as dissociation constant by BROMOscan LeadHunter assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/19/2024
Entry Details
PubMed
TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665375(US20240116910, Compound 59)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665455(US20240116910, Compound 139)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665457(US20240116910, Compound 141)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665544(US20240116910, Compound 228)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665452(US20240116910, Compound 136)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665451(US20240116910, Compound 135)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665364(US20240116910, Compound 48)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665369(US20240116910, Compound 53 | (2S)-2-({5-[(1S)-1-[(...)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665410(US20240116910, Compound 94)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665403(US20240116910, Compound 87)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein phosphatase 1D [2-420](Human)
PMV Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM665459(US20240116910, Compound 143)
Affinity DataIC50: 5nMAssay Description:Test compounds (252 mM stock in DMSO) were diluted 3 folds in series in DMSO and 1.2 μl per well were added into 384-well polypropylene black pl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/29/2024
Entry Details
Go to US Patent

TargetProtein polybromo-1 [645-766](Human)
Genentech

US Patent
LigandPNGBDBM394605(US10308614, Example 209 | 2-(6-amino-5-cyclohexylp...)
Affinity DataIC50: 5.20nMAssay Description:Histidine-Flag-PB1-BD5 Bromodomain645-766 (S645-D766; Swiss Prot Q86U86; mhhhhhhasdykddddkgslvprgsSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAI FLRLPSRSELP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetProtein polybromo-1 [645-766](Human)
Genentech

US Patent
LigandPNGBDBM394575(US10308614, Example 178 | 2-(6-amino-5-(2-)
Affinity DataIC50: 5.30nMAssay Description:Histidine-Flag-PB1-BD5 Bromodomain645-766 (S645-D766; Swiss Prot Q86U86; mhhhhhhasdykddddkgslvprgsSGISPKKSKYMTPMQQKLNEVYEAVKNYTDKRGRRLSAI FLRLPSRSELP...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/15/2020
Entry Details
Go to US Patent

TargetProtein phosphatase 3 catalytic subunit alpha(Human)
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50079782(17-Ethyl-1,14-dihydroxy-12-(2-{4-[2-hydroxy-2-(3-t...)
Affinity DataIC50: 5.90nMAssay Description:Inhibitory activity against Calcineurin (CaN phosphatase)More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
Displayed 1 to 50 (of 1117 total ) | Next | Last >>
Jump to: